As we continue National Women’s Health Week, we are highlighting research published in Human Reproduction Update by Dewailly et al that explores the role of Anti-Müllerian hormone (AMH) in female reproductive health. While on the FACTS elective, Megan Harman summarized this 2014 study [1] that discusses why AMH may represent a useful marker of fertility for women across the reproductive lifespan.
Angel Marquez, DO, a former FACTS elective participant, highlighted how fertility awareness-based methods (FABMs) can empower women and men with knowledge about their fertile window, as well as explore the dietary and lifestyle factors that can contribute to infertility. He also illustrates why it is so important for physicians and medical professionals to learn more about these methods in order to help their patients address infertility with empathy and professionalism.
This compelling interview with a family physician in Ontario, Canada explores ways to integrate fertility awareness-based methods (FABMs) into clinical practice and medical education.
Summarizing a research review by Gordon et al, former FACTS elective student Anish Patel teaches us about the application of transdermal estradiol combined with micronized progesterone to address depressive symptoms in this population.
Sabel Hicks, a former FACTS elective student, interviewed Jeni,* a friend who has been using fertility awareness-based methods (FABMs) to track her cycle for years.
This research published in Psychoneuroendocrinology by researchers Kimbal et al. analyzed the allopregnanolone-to-progesterone ratio across the menstrual cycle and in menopause. Deepa Manda, a former FACTS elective participant, summarized this 2020 study, discussed how allopregnanolone might connect to mental health, and noted that this hormone might one day become a part of the hormonal assessment done in various fertility awareness-based methods.